753 research outputs found

    An examination of semantic impairment in amnestic MCI and AD : What can we learn from verbal fluency?

    Full text link
    Introduction The Verbal Fluency Test (VF) is commonly used in neuropsychology. Some studies have demonstrated a marked impairment of semantic VF compared to phonemic VF in Alzheimer’s disease (AD). Since amnestic Mild Cognitive Impairment (aMCI) is associated with increased risk of conversion to incident AD, it is relevant to examine whether a similar impairment is observed in this population. The objective of the present empirical study is to compare VF performance of aMCI patients to those of AD and elderly controls matched one-to-one for age and education. Method Ninety-six participants divided into three equal groups (N = 32: AD, aMCI and Controls) were included in this study. Participants in each group were, on average, 76 years of age and had 13 years of education. A repeated measures ANOVA with the Group (AD, aMCI, NC) as between-subject factor and the Fluency condition (“P” and “animals”) as within-subject factor was performed. T-tests and simple ANOVAs were also conducted to examine the interaction. Results There was a significant interaction between the groups and the verbal fluency condition. In AD, significantly fewer words were produced in both conditions. In contrast, participants with aMCI demonstrated a pattern similar to controls in the phonemic condition, but generated significantly fewer words in the semantic condition. Conclusion These results indicate a semantic memory impairment in aMCI revealed by a simple, commonly-used neuropsychological test. Future studies are needed to investigate if semantic fluency deficits can help predict future conversion to AD

    Reuse of treated wastewater in viticulture: Can it be an alternative source of nutrient-rich water?

    Get PDF
    Water scarcity is a global problem, which leads to unprecedented pressure on water supply in arid and semi-arid regions. Treating wastewater is an alternative and valuable water resource, therefore its reuse for agricultural irrigation has been growing worldwide since the beginning of the 21st century. In several regions of the wine-producing countries subject to significant water stress (e.g., Australia, California-USA, Spain), wastewater recycling appears to be the most accessible alternative, both financially and technically, for the agricultural uses that notably not requiring drinking water. Therefore, this research was planned to quantify the contribution of treated wastewater (TWW) to fertilization-needs of the vine, evaluate the impact of irrigation with TWW on the soil, vegetative growth, yield, and wine and grape juice composition. The results provide scientific and technical knowledge on a strategy of water management with high added value. The fertilizer contribution of the TWW would be important, according to the plant's nutrient needs (e.g., in this study 19–39 Unit N, 0.5–1.1 Unit P and 14–28 Unit K ha−1 were supplied with TWW). Ensuring treated wastewater microbiological quality is essential, but without reducing of its nutrients. These nutrients would be a valuable input for crop growth and yield, and could reduce the need to resort for inorganic/synthetic fertilizers. A sustainable use of treated wastewater over the long term would, however, necessitate a good practice guidelines and an integrated vision of treated wastewater quality, crops, irrigation and post-harvest practices

    Maitrise de la salinité des eaux d'irrigation pour la viticulture

    Get PDF
    MĂȘme si la vigne reste parmi les plantes cultivĂ©es une des plus Ă©conomes en eau, se pose maintenant la question de la disponibilitĂ© et de l'accessibilitĂ© Ă  la ressource en eau naturelle de qualitĂ©: eaux souterraines (infiltration, nappes), eaux de surface stagnantes (lacs, retenues de barrages) ou en Ă©coulement (riviĂšres, fleuves), eaux de mer, eaux usĂ©es traitĂ©es (REUT). Certaines de ces eaux peuvent contenir des composĂ©s d'intĂ©rĂȘts nutritionnels pour les plantes, mais aussi ĂȘtre riches en sels dissous. L'objet de cette communication est d'Ă©tudier les technologies permettant d'affiner la teneur en sel de l'eau d'irrigation pour la vigne, quel que soit son origine et son niveau initial. Les techniques membranaires, osmose inverse, nanofiltration et Ă©lectrodialyse sont ainsi comparĂ©es techniquement et Ă©valuĂ©es Ă©conomiquement. Les unes, nanofiltration et osmose inverse, Ă  partir de membranes poreuses ou denses sous pression, consiste en une sĂ©paration de quasi tous les Ă©lĂ©ments dissous de l'eau (anions, cations, mais y compris les nutriments azotĂ©s, et minĂ©raux) et ce quel que soit, pour l'osmose inverse, la salinitĂ© de l'eau initiale (e.g. eau de mer). L'autre l'Ă©lectrodialyse, Ă  partir de membranes denses ne filtre pas l'eau, mais extrait une quantitĂ© pilotable en ligne, de sels dissous (Na+ et Cl− en particulier sĂ©lectionnables) sous l'effet d'un champ Ă©lectrique, afin de l'adapter aux sols ou plantes concernĂ©

    On POD analysis of PIV measurements applied to mixing in a stirred vessel with a shear thinning fluid

    Get PDF
    P.O.D. technique is applied to 2D P.I.V. data in the field of hydrodynamics in a mixing tank with a Rushton turbine and a shear thinning fluid. Classical eigen-value spectrum is presented and phase portrait of P.O.D. coefficients are plotted and analyzed in terms of trailing vortices. A spectrum of dissipation rate of kinetic energy is introduced and discussed. Length scales associated to each P.O.D. modes are proposed

    A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

    Get PDF
    There is clinical evidence to suggest that tumour necrosis factor-α (TNF-α) may be a therapeutic target in renal cell carcinoma (RCC). Multi-targeted kinase inhibitors, such as sorafenib and sunitinib, have become standard of care in advanced RCC. The anti-TNF-α monoclonal antibody infliximab and sorafenib have differing cellular mechanisms of action. We conducted a phase I/II trial to determine the safety and efficacy of infliximab in combination with sorafenib in patients with advanced RCC
    • 

    corecore